Interv Akut Kardiol. 2005;4(3):131

Current use of vena cava filters in the treatment of venous trombembolism

Miroslav Solař
Kardiochirurgická klinika LF UK a Kardiocentrum FN Hradec Králové

Žilní trombembolizmus patří mezi významné příčiny mortality a morbidity v naší populaci. Základní léčebnou strategií je antikoagulační terapie. Mezi další způsoby léčby patří obstrukce žilního systému s cílem zabránit plicní embolizaci. Jde o historicky nejstarší způsob léčby žilního trombembolizmu(1). První ligace femorální vény byla popsána v roce 1874. Chirurgické přerušení dolní duté žíly ligací nebo plikací bylo prováděno od poloviny 40. let 20. století. Tyto operační postupy však byly spojeny s významnou operační mortalitou a častými známkami závažné venostázy(2). Od 70. let se k mechanickému přerušení dolní duté žíly používají endovazálně zaváděné kavální filtry. Původní operační zavedení pod skiaskopickou kontrolou bylo od roku 1984 postupně nahrazeno perkutánním přístupem.

Keywords: -

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Solař M. Current use of vena cava filters in the treatment of venous trombembolism. Interv Akut Kardiol. 2005;4(3):131.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Girard P, Stern JB, Parent F. Medical literature and vena cava filters: so far so weak. Chest 2002; 122(3): 963-967. Go to original source... Go to PubMed...
    2. Kinney TB. Update on inferior vena cava filters. J Vasc Interv Radiol 2003; 14(4): 425-440. Go to original source... Go to PubMed...
    3. Decousus, Herve, Leizorovicz, Alain, Parent et al. A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis. N Engl J Med 338(7), 409-416. 98.
    4. The PREPIC Study Group. Eight-Year Follow-Up of Patients With Permanent Vena Cava Filters in the Prevention of Pulmonary Embolism: The PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) Randomized Study. Circulation 2005; 112(3): 416-422. Go to original source... Go to PubMed...
    5. Greenfield LJ, Rutherford RB. Recommended reporting standards for vena caval filter placement and patient follow-up. Vena Caval Filter Consensus Conference. J Vasc Interv Radiol 1999; 10(8): 1013-1019. Go to original source... Go to PubMed...
    6. Streiff MB. Vena caval filters: a comprehensive review. Blood 2000; 95(12): 3669-3677. Go to original source...
    7. Goldhaber, Samuel Z. and Tapson, Victor F. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. The American Journal of Cardiology 2004; 93(2): 259-262. Go to original source... Go to PubMed...
    8. Stein PD, Kayali F, Olson RE. Twenty-one-year trends in the use of inferior vena cava filters. Arch Intern Med 2004; 164(14): 1541-1545. Go to original source... Go to PubMed...
    9. Lang W, Schweiger H, Hofmann-Preiss K. Results of long-term venacavography study after placement of a Greenfield vena caval filter. J Cardiovasc Surg (Torino) 1992; 33(5): 573-578. Go to PubMed...
    10. Kanter B, Moser KM. The Greenfield vena cava filter. Chest 1988; 93(1): 170-175. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.